Corporate Profile
Landos Biopharma, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of novel oral therapeutics for patients with autoimmune diseases. Our pipeline, which currently contains seven preclinical and clinical product candidates, leverages our LANCE precision medicine platform to optimally identify novel immunometabolic targets and address a wide range of disease indications.
Learn more about our broad inflammation & immunology clinical pipeline.